FHLBank announces return of popular HomeBoost Down Payment Assistance Program with $5 million allocation
18 juil. 2024 14h54 HE
|
Federal Home Loan Bank of Indianapolis
The Federal Home Loan Bank of Indianapolis is relaunching the HomeBoost Down Payment Assistance Program with double the allocation this year — $5 million.
SAGA Metals Receipts Final Prospectus and Receives Conditional Approval to List on the TSX Venture Exchange
17 juil. 2024 09h00 HE
|
Saga Metals Corp.
SAGA METALS RECEIPTS FINAL PROSPECTUS AND RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TSX VENTURE EXCHANGE
Ancilia Biosciences Announces Closing of $4.2 Million Financing
17 juil. 2024 07h00 HE
|
Ancilia Biosciences
Ancilia raised $4.2M to leverage CRISPR’s natural function to create bacterial therapies with immunity against the viruses that limit their effectiveness.
Alaska Energy Metals Announces Automatic Conversion of Special Warrants
15 juil. 2024 23h54 HE
|
Alaska Energy Metals Corporation
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States. ...
SAGA Metals Announces Filing of Final Prospectus for Critical Mineral IPO
15 juil. 2024 09h00 HE
|
Saga Metals Corp.
SAGA Metals Announces Filing of Final Prospectus for Critical Mineral IPO
Alaska Energy Metals Announces Closing of Side Car Unit Offering
11 juil. 2024 20h20 HE
|
Alaska Energy Metals Corporation
Not for distribution to United States newswire services or for release publication, distribution, or dissemination, directly or indirectly, in whole or in part, in or into the United States. ...
Orezone Announces US$105 Million Financing to Fully Fund the Bomboré Phase II Hard Rock Expansion
10 juil. 2024 06h30 HE
|
Orezone Gold Corporation
VANCOUVER, British Columbia, July 10, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to announce that the Company has secured...
HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration
10 juil. 2024 03h00 HE
|
HepaRegeniX GmbH
Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regenerationElias Papatheodorou moves from Chair of the Board to CEO of...
Crossject obtient 6,9 millions d'euros de financement public dans le cadre du plan France 2030, pour accélérer le développement de ZENEO® Adrénaline
10 juil. 2024 01h30 HE
|
CROSSJECT
Contribution clé à l'accélération du développement de ZENEO® AdrénalineSoutien financier composé majoritairement de subventions, et d’avances remboursablesFrance 2030 a vocation à soutenir les...
Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine
10 juil. 2024 01h30 HE
|
CROSSJECT
Key contribution to the acceleration of the development of ZENEO® EpinephrineFinancial support includes mainly grants, as well as subsidized loansFrance 2030 Plan dedicated to supporting French...